
Home » Abiraterone Tx Boosts Survival in Prostate Cancer
Abiraterone Tx Boosts Survival in Prostate Cancer
Final results of a phase III trial confirm that treatment with abiraterone prolongs overall survival in metastatic castration-resistant prostate cancer that has progressed after docetaxel therapy.
MedPage Today
MedPage Today
Upcoming Events
-
28Sep
-
28Sep
-
11Oct
-
16Oct
-
26Oct
-
08Nov